CXCL2 and neoplasm: These results indicate that HMGB1, released from GSDMC‐mediated pyroptotic cells, enhances CXCL2 expression in tumor cells, and the elevated CXCL2 subsequently recruits CXCR2+ MDSCs to orchestrate the immunosuppressive TME.